Listen in to this webinar to learn more about a potential clinical trial for your patients. The RAMP 301 trial is evaluating the novel combination of avutometinib + defactinib versus investigator’s choice of therapy in patients with recurrent low grade serous ovarian cancer. Monday, April 15 at 7:00 PM UTC (see all time zones) Duration approximately 30 minutes Attended previous IGCS webinars? If you have attended IGCS webinars in the past, you may already have an IGCS account and creating a new account is not required. If unsure of your login information, you may reset your information by selecting "Forgot Password" at login or contact education@igcs.org. If you have questions or need assistance, contact education@igcs.org.
Rachel Grisham, MDSection Head Ovarian CancerDirector, Gynecologic Medical OncologyMemorial Sloan Kettering Cancer CenterUSA
Susana Banerjee, MBBS, MA, PhD, FRCPConsultant Medical OncologistResearch Lead Gynaecology Unit The Royal MarsdenUK